Amphadase Approval History
- FDA approved: Yes (First approved October 26th, 2004)
- Brand name: Amphadase
- Generic name: hyaluronidase
- Dosage form: Injection
- Company: Amphastar Pharmaceuticals, Inc
- Treatment for: Adjuvant to increase the absorption and dispersion of other injected drugs
Amphadase (hyaluronidase) used as an adjunctive agent to facilitate the dispersion and absorption of other drugs.
Development History and FDA Approval Process for Amphadase
|Oct 26, 2004||Amphadase Amphastar Pharmaceuticals, Inc - Treatment for Adjunctive Agent|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.